Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367978
Status:
COMPLETED
Last Update Posted:
2011-11-08
First Post:
2006-08-23
Brief Title:
Effects of AmlodipineBenazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Randomized Multicenter Study to Determine the Efficacy and Safety of AmlodipineBenazepril Hydrochloride Versus Enalapril in the Treatment of Hypertension in an African-American Population With Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluated the efficacy and safety of amlodipinebenazepril compared with that of enalapril in the treatment of hypertension in African-American patients with type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None